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Abstract Specific and non-specific interactions of SsolI re- 
striction endonuclease (R.SsoII) were probed by the method of 
covalent attachment o modified DNA containing an active 
monosubstituted pyrophosphate internueleotide bond instead of a 
phosphodiester one. R.SsoII with six N-terminal His residues 
was shown to be cross-linked to duplexes with this type of 
modification, either containing or not the recognition sequence. 
Competition experiments with covalent attachment of R.SsoII to 
activated DNAs demonstrated the similar affinity of the enzyme 
to cognate and non-cognate DNAs in the absence of cofactor, 
Mg 2+ ions. 
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1. Introduction 
Recently it was established that a number of restriction 
endonucleases require Mg 2+ ions, not only for catalysis but 
also for the specificity of substrate recognition [1]. For  exam- 
ple, restriction endonuclease EcoRV interacts with cognate 
and non-cognate DNAs with nearly equal affinity in the ab- 
sence of cofactor [2], as revealed by nitrocellulose binding or 
electrophoretic mobility shift assay. In the present paper we 
investigated the specific and non-specific interactions of the 
restriction endonuclease SsolI (R.SsolI) with DNAs by the 
method of covalent attachment of the enzyme to activated 
DNA. We chose DNA duplexes containing a monosubstituted 
pyrophosphate internucleotide bond instead of a phosphodi- 
ester one in the enzyme recognition site as reagents for affinity 
modification of R.SsolI. These activated DNA duplexes were 
recently shown to successfully modify the active centers of 
restriction endonucleases RsrI, EcoRI [3], EcoRII  [4,5] and 
MvaI [5]. Covalent attachment may occur on the binding or 
catalytic step depending on cross-linking conditions. 
SsolI endonuclease encoded by pQESso9 plasmid possessed an N- 
terminal 6 × His affinity tail, making it possible to purify the enzyme 
to virtual homogeneity by one-step Ni-chelate affinity column chro- 
matography. The introduced amino acid substitutions do not change 
R.SsolI recognition and cleavage properties if compared with the un- 
modified enzyme obtained earlier [8]. 
Oligonucleotide precursors were synthesized by T.S. Oretskaya, 
E.M. Volkov and E.A. Romanova s described in [9]. DNA duplexes 
with a monosubstituted pyrophosphate internucleotide bond for 
cross-linking to R'SsolI were synthesized as described in [10]. DNA 
duplex I with an ethoxy or isopropoxy group and DNA duplexes II 
and III with an ethoxy group in modified internucleotide linkage were 
obtained (Table 1). DNA duplexes were a2p-labeled by T4 polynucleo- 
tide kinase. 32p label was at the monosubstituted phosphate group of 
the modified internucleotide linkage of the DNA duplex modified 
strand (see formulae) and at the 5' end of the non-modified strand. 
Cleavage analysis of DNA duplexes by R.SsolI was performed as 
described in [11]. 
2.2. Cross-linking experiment 
Cross-linking of R.SsolI (concentration per monomer 1.4 × 10 -6 M) 
to substrates I-III (concentration per duplex 1.8 × 10 -7 M) was per- 
formed in 20 pJ of buffer A: 10 mM N-methylimidazole (Melm), pH 
7.5, 50 mM NaC1, 0.1 mM dithiothreitol (DTr) and 0, 0.15 or 15 mM 
MgC12, or B: 10 mM Tris-HC1, pH 7.5, 50 mM NaC1, 0.1 mM DTT 
and 0, 0.15 or 15 mM MgC12 at 37°C for 18 h. DNA duplexes I-III 
contained 32p-label only at the monosubstituted phosphate group of 
modified intemucleotide linkage (see formulae). Reactions were fol- 
lowed by 0.1% SDS-10% PAGE [12] after heating samples in 0.1% 
SDS-2-mercaptoethanol solution at 95°C. The gels were analyzed by 
autoradiography and staining with Coomassie blue. The coincidence 
of the radioactive band and the band containing protein proved the 
formation of the DNA-enzyme covalent complex. Cross-linking yield 
was determined as the ratio of the radioactivity of the DNA-enzyme 
covalent complex to the total radioactivity of the conjugate and the 
unbound DNA. The average results for cross-linking of R.SsolI to 
duplexes I and II are reported in Table 2. 
2.3. Competition inhibition of R.SsoH cross-linking to duplexes with a 
monosubstituted pyrophosphate internucleotide bond 
Competition i hibition of R.SsolI cross-linking to duplexes I and II 
was studied in the presence of increasing amounts of unlabeled DNA 
duplexes IV and V added to reach ratios of molar concentrations of
inhibitor and reagent equal to 0.5, 1, 2, 3, 4, 5, 7, 10, 14, 21, 28. 
Conditions of the reactions: buffer B, 37°C, 18 h. 
2. Materials and methods 3. Results and discussion 
2.1. Enzymes and oligonucleotides 
R.SsolI (10000 U/ml) was purified from E. coli M15 cells carrying 
the isopropyl-13-o-thiogalactopyranoside (IPTG)-inducible overexpres- 
sion plasmid pQESso9 [6]. This plasmid contained the R.SsolI gene [7] 
in the pQE9 tac expression vector (DIAGEN GmbH, Germany). The 
*Corresponding author. Fax: (7) (95) 939-31-81. 
Abbreviations: Melm, N-methylimidazole; DTT, dithiothreitol 
R'SsolI recognizes the double stranded sequence 
5' ...~ CCNGG ... 3' 
3' ... GGNCCI  ... 5' 
degenerated at the central position and cleaves it as shown by 
arrows. 
For the affinity modification of R.SsoII, we used 32P-labeled 
DNA duplexes I and II containing the recognition site of this 
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Fig. 1. Dependence of 14-mer canonical DNA duplex cleavage xtent by R.SsoII on Mg 2+ ion concentration. Cofactor concentration is ad- 
duced in logarithmic scale. 37°C, 1 h, buffer B. 
enzyme (Table 1), 32p label being located in the disubstituted 
phosphate group of the pyrophosphate. DNA duplex I con- 
tained the activated pyrophosphate group in the middle of the 
R.SsolI recognition sequence (marked in bold). In duplex II, 
the monosubstituted pyrophosphate bond was adjacent to the 
recognition site and coincided with the R.SsolI scissile bond. 
Covalent attachment of the nucleophilic agent o the modified 
strand of the duplex follows the scheme 
O O O O 
II II. Jl II. 
RO--P (3- + Nu P--OR' RO--P-O;-P--OR'.,. --- , , 
X [O-  --H+ X O- 
NuH 
where Nul l  is a nucleophilic agent, RO and R'O are oligo- 
nucleotide residues, X is a non-nucleotide substituent, and P* 
is the 32p label. 
Ethoxy or isopropoxy groups were chosen as non-nucleo- 
tide substituents. The introduction of an additional methyl 
group into the non-nucleotide substituent of the modified in- 
ternucleotide linkage does not influence the interaction be- 
tween activated DNA and proteins (unpublished results). 
The nucleophilic amino acid side chains of R.SsolI are sup- 
posed to be attached to oligonucleotide *pTGGTGGT from 
duplex I or *pCCTGGATCCG from duplex II during the 
cross-linking reaction [I0]. 
The capability of R.SsolI to bind DNAs with modification 
of the sugar-phosphate backbone was demonstrated bythe gel 
retardation assay (data not shown). Introduction of a mono- 
substituted pyrophosphate bond does not prevent he hydro- 
lysis of duplexes I and II by R.SsolI (Table 1). 
The data on cross-linking of oligonucleotides from duplexes 
I and II to R.SsolI are adduced in Table 2. One can see that 
the yield of cross-linking varies from 2 to 22% in buffer B 
(Tris-HC1 buffer) in the absence of cofactor, Mg 2+ ions. We 
tried to get higher yields of cross-linking with the help of the 
nucleophilic atalyst Melm which was previously shown to 
increase the efficiency of restriction endonuclease attachment 
to the same type of activated DNA [3-5]. But the presence of 
Melm did not result in an increase of the extent of cross- 
linking of R.SsolI to duplexes I and II in comparison with 
Table 1 
R.SsolI hydrolysis of DNA duplexes I and II in buffer B 
DNA duplex Strand I Cleav~e, 
% 
Alk~ ?? a 29 
5' ACC~ACC-O-P--O--P--O-TGG~GG~ 3' 
8 
3' TGGATGC ACCACCA 5 b 34 
1")  
c2n~? 9- **) 
5' GTCACT-O-P - -o - -pLo -CCTGGATCCG 3' a 
~ .. 
3' CAGTGA-  GGACCTAGGCA 5 b 51 
*Alk=iC3H7. 
**The extent of hydrolysis was not determined due to the coincidence 
of the scissile bond and the modified internucleotide bond. 
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that in Tris-HC1 buffer (Table 2). 
There is a tendency that introduction of Mg 2+ ions causes a 
decrease of cross-linking of R.SsoII to duplex I. Comparing 
data of Table 2 and Fig. 1, one can conclude that this de- 
crease is connected with substrate hydrolysis at Mg 2+ concen- 
trations higher than 1.5 × 10 -4 M. In the case where the mod- 
ified internucleotide bond coincides with the scissile bond 
(duplex II), addition of Mg 2+ ions does not influence the 
cross-linking yield. 
To investigate the specificity of R.SsoII cross-linking to 
duplexes I and II we (i) checked the possibility of affinity 
modification of R.SsoII by activated DNA duplex III without 
the R.SsoII recognition site 
C2H50 O~ 
5' TGGCC-O-  b -O- I~-O-GTCGTIT  3' 
LI . . . . .  O 6 . . . . . . .  (II I) 
3' TGACCGG CAGCAAAATG 5' 
and (ii) tested the possibility of inhibition of cross-linking of 
reagents (DNA duplexes I and II) by non-modified duplexes 
with (IV) or without (V) recognition site 
100 
• = 75 * 
~ 2s 
. t 
0 5 10 15 20 25 30 
Ratio inh ib i tor / reagent  
Fig. 2. Dependence of affinity modification of R.SsoII by duplexes I 
(Alk=iC3HT) and II on the ratio of duplexes IV or V to I or II. 
Concentration of duplexes I and II per duplex is 1.8×10 -7 M. 
Yield of R.SsoII affinity modification by duplexes I and II in the 
absence of IV and V is referred to as 100%. 37°C, 18 h, buffer B. 
5' GCCAACCTGGCTCT 3' ( IV )  
. . . .  ° . . . . . . . . .  
3 ' CGGTTGGACCGAGA 5 ' 
5 ' GCTGGTGGCTCGAC 3 ' 
3 ' CGACCACCGAGCTG 5' (V) 
Duplex IV had a different nucleotide sequence from that of 
duplexes I and II in order to prevent overcomplicated ffects 
of strand exchange during the cross-linking reaction in the 
presence of both reagent and inhibitor. 
The ability of duplex III to modify R.SsolI was shown with 
a cross-linking yield of 11% (buffer B without Mg 2+ ions). 
The results of the competition inhibition by duplexes IV 
and V in buffer B without Mg 2÷ ions are shown in Fig. 2. 
A 7-fold excess of substrate IV completely inhibits the cova- 
lent attachment of R.SsolI to duplex I. However, the trend to 
a decrease of the yield of the DNA-protein covalent complex 
is observed also in the presence of duplex V. 
We consider the covalent attachment of substrate to enzyme 
to be specific when it occurs within the catalytic domain of the 
protein. The inhibition of the cross-linking reaction of R.SsolI 
Table 2 
Dependence of the extent of R.SsoII affinity modification by du- 
plexes I and II on buffer solution content, 37°C, 18 h (%) 
Duplex Yield of cross-linking (%) 
Conditions 
Melm buffer* Tris-HC1 buffer** 
MgC12 concentration (M) MgC12 concentrantion (M) 
0 1.5×10 -4 1.5x10 -2 0 1.5×10 -4 1.5×10 -2 
I*** 19 17 2 22 20 5 
II 5 5 2 6 
*Buffer A, see Section 2.2. 
**Buffer B, see Section 2.2. 
***Alk=C2H~. 
to duplexes I and II by substrate IV demonstrates that the 
covalent bond between the enzyme and DNA is formed at the 
active site of the enzyme. 
DNA duplex V also inhibits the covalent attachment of 
R.SsoII to duplex I though at a higher concentration (Fig. 
2). The inhibition of cross-linking by duplex V as well as 
the successful attachment to duplex III demonstrates that 
non-cognate DNAs can also interact with the active center 
of the protein. We suggest hat interaction of R.SsoII with 
cognate and non-cognate DNAs appears in the same protein 
domain. R.SsoII has the higher affinity to substrates which 
can be accounted as KS/K I to be equal to [I]5o/[R]5o][S]5o/ 
[R]50, where K s and K I are constants of specific and non- 
specific association, [I]50/[R]~0 and [S]50/[R]~0 are ratio inhibi- 
tor/reagent for non-cognate (V) and cognate (IV) inhibitor 
respectively, at which cross-linking efficiency decreases 2- 
fold. This value is equal approximately 3/1 (see Appendix A). 
It is known that all DNA acting enzymes recognize non- 
specific DNA sequences. However, usually the constant 
of specific interaction differs from the non-specific one by 
2 [13,14] or even 4-5 [15] orders of magnitude as was 
established by kinetic investigations [13] or binding assays 
on nitrocellulose filters [14,15]. From this point of view, it is 
interesting to note that R.SsoII constants of specific and non- 
specific interaction with DNA have the same order of magni- 
tude in the absence of Mg 2+ ions. 
So by the method of cross-linking of R.SsoII with the six 
N-terminal His residues to duplexes with a monosubstituted 
pyrophosphate internucleotide bond, it was established that 
the enzyme is a member of the family of restriction endonu- 
cleases that require Mg 2+ not only for the catalytic act, but 
also for specific recognition of cognate DNA. 
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Appendix 
Calculation of the ratio of constants of specific and non-specific 
association 
Consider the case when two equilibria occur 
ES ~ SE ~ RER -~ ERcL 
where E is enzyme; S is substrate; R is reagent for cross- 
linking; ERcL is product of covalent attachment of the en- 
zyme to reagent; ER and ES are enzyme-reagent and enzyme- 
substrate complexes respectively. 
Thermodynamic constants can be written as 
KR = [ER] Ks - [ES] 
[E][R--~; [E][S] 
for enzyme-reagent and enzyme-substrate complexes respec- 
tively. 
Their ratio will be equal to 
r~ ~ [ER] [E] [S] _ [ER] [S] 
K ~ = ~S] [El [R] - [ES] [R] 
A 2-fold decrease of cross-linking indicates that half of the 
busy active centers are occupied by the substrate rather than 
reagent, in this case [ES]=[ER] and 
K rt [S]5 o 
K s [R]50 
where [S]50/[R]50 is ratio substrate/reagent (i.e. duplex IV/du- 
plex I) in the case where cross-linking efficiency is equal to 
50% of the initial (or decreases 2-fold). 
In the similar case 
EI o IE o aER ~ ERcL 
where I is non-cognate DNA inhibitor and EI is complex of 
the enzyme with non-cognate DNA inhibitor (i.e. duplex V), 
Z R [115 0
K I [R]50 
where [I]50/[R]50 is ratio inhibitor/reagent (i.e. duplex V/duplex 
I) in the case where cross-linking efficiency is equal to 50% of 
the initial (or decreases 2-fold). Distributing KR/K I by Krt/K s 
we get 
KR/K I _ K s [I]50/[R]50 
KR/K s K I [S]50/[R]50 
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